FindTrial
Sign In

A clinical trial to study the effects of nebulised hypertonic saline in bronchiolitis

Nebulised Hypertonic Saline Compared with Epinephrine in Bronchiolitis using CUSUM: A Novel Statistical Tool for Continuous Monitoring of New Therapy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2008/091/000233
Enrollment
Unknown
Registered
2008-11-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nebulised hypertonic (3%) saline: 6 hourly Control Intervention1: Nebulised epinephrine: 1 mL(0.1%)epinephrine + 2 mL normal saline 6 hourly

Sponsors

J M Puliyel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All children (2 months to 2 years) admitted in pediatric ward with first episode of acute bronchiolitis

Exclusion criteria

Exclusion criteria: Children with history suggestive of chronic cardiopulmonary disease, immunodeficiency, past history of respiratory disease requiring nebulisation and critical illness

Design outcomes

Primary

MeasureTime frame
1) Respiratory distress score 2) Length of hospital stayTimepoint:—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr. J M Puliyel

Nil

drneeraj79@yahoo.co.in0119871070375

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026